Terumo Neuro (MicroVention)

About Terumo Neuro (MicroVention)

Terumo Neuro (formerly MicroVention) — neurovascular medical technologies in Aliso Viejo About Terumo Neuro Terumo Neuro is the name used for the neurovascular business previously known as MicroVention. The company is part of the Terumo group and has a Worldwide Innovation Center and global headquarters at 35 Enterprise in Aliso Viejo, California. Its published history describes the development of catheter-based devices for physicians treating cerebrovascular disorders. This Orange County business listing describes a medical-device manufacturer and research operation, not a place where patients can walk in for neurological examinations or emergency stroke treatment. Neurovascular catheter technologies Terumo Neuro publishes a range of intracranial and neurovascular support catheters, microcatheters and related tools. These devices are used by appropriately trained specialists as parts of endovascular procedures. Different catheter designs have different dimensions, access routes and intended uses. A hospital evaluating one must use the current instructions for use, regulatory indications, compatibility tables and clinical protocols. A product family name does not establish that it is appropriate for a specific patient or anatomy. Aneurysm treatment devices The company's portfolio includes embolization coils and other devices used in selected neurovascular interventions. Its official communications discuss HydroCoil technology as well as flow-diversion and intrasaccular devices. These products follow different approaches to treating cerebral aneurysms, and their clinical suitability is a matter for qualified care teams. A directory entry cannot compare personal treatment risks, recommend a device or replace advice from a licensed specialist. Stroke intervention equipment Terumo Neuro has described its SOFIA catheter line and additional equipment within a stroke-intervention portfolio. Public product announcements identify support catheters, retrieval devices, balloon guides, microcatheters and guidewires. The availability, indications and approved configurations of a given system depend on region and regulatory status. Clinicians and hospital procurement staff should read the latest manufacturer labeling instead of inferring current authorization from an older launch announcement. Professional audiences The company's users and business contacts include interventional neuroradiologists, endovascular specialists, hospital procurement groups, clinical educators, medical-device distributors and healthcare researchers. Its presence in Aliso Viejo also matters to Orange County's medical-technology manufacturing, engineering and employment sectors. Patients seeking treatment should speak with a licensed healthcare provider; this listing does not accept medical referrals. Orange County location The verified innovation-center address is 35 Enterprise, Aliso Viejo. Patients and visitors should not assume that the headquarters operates as a clinical treatment facility. Staff, vendors and job applicants should arrange contact through the relevant official company department. Aliso Viejo is the recorded office city, while Laguna Niguel, Laguna Hills and neighboring communities are geographic context, not additional headquarters. How healthcare organizations evaluate neurovascular suppliers A buying team should confirm device labeling, intended use, dimensions, ordering channels, technical training and post-market support. Hospitals also need to consider clinician education, purchasing policies, sterilization and inventory handling. Request the current product literature and any applicable safety information directly from the manufacturer; avoid relying on general promotional comparisons. Frequently asked questions Q: Is Terumo Neuro connected to MicroVention? A: Yes, the company announced its rebranding from MicroVention to Terumo Neuro in 2024. Q: Where is its Aliso Viejo operation? A: The worldwide innovation center is at 35 Enterprise. Q: Does it make devices for aneurysm treatment? A: Its published portfolio includes embolic coils, flow-diversion and other neurovascular technologies. Q: Is headquarters a hospital? A: No. It is a medical-technology business location. Q: Can OCDIR recommend a catheter for a patient? A: No, that requires clinical assessment and current device-specific information. Official sources: https://www.terumoneuro.com/newsroom/press-releases/microvention-rebrands-to-terumo-neuro-reflects-expanded-focus-and-strategic ; https://www.terumoneuro.com/newsroom/press-releases/microvention-expands-worldwide-innovation-center ; https://www.terumoneuro.com/